Document is current
Any future updates will be listed below
-
Authors
Zugaj, Marco Richard https://orcid.org/0009-0007-3173-3214
Germeyer, Ariane
Kranz, Karina
Züger, Andrea
Keßler, Jens
-
Funding
Funding for this research was provided by:
Stiftung der Landesbank Baden-Württemberg (2022-198/N)
Medizinische Fakultät Heidelberg der Universität Heidelberg
- License Information
-
More Information
Article History
Received: 28 March 2024
Accepted: 12 July 2024
First Online: 27 July 2024
Declarations
:
: AG Advisory Boards: Ferring, Gedeon Richter, Novartis, HEREA; Stock ownership: Edwards, Mpc, Novo Nordisk, Siemens Health, Viatris; Interest groups boards: Fertiprotect Netzwerk e.V., URZ, Züricher Gesprächskreis, DVR MRZ, KK, AZ and JK declare no conflicts of interest relating to this paper.
: All human studies described were carried out with the approval of the responsible ethics committee, in accordance with national law and in accordance with the Declaration of Helsinki of 1975 (in the current, revised version). Informed consent was obtained from all patients involved.
